Cargando…
LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma
Background: Asparaginase (ASP) is the cornerstone drug in the treatment of extranodal NK/T-cell lymphoma (ENKTCL), and the mechanisms of resistance to ASP remain largely unknown. Long non-coding RNAs play important roles in chemotherapy resistance in various cancers. However, the expression of BCYRN...
Autores principales: | Wang, Liang, Yang, Jing, Wang, He-nan, Fu, Rui-ying, Liu, Xin-di, Piao, Ying-shi, Wei, Li-qiang, Wang, Jing-wen, Zhang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738865/ https://www.ncbi.nlm.nih.gov/pubmed/33391513 http://dx.doi.org/10.7150/thno.46655 |
Ejemplares similares
-
Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase
por: Wang, Liang, et al.
Publicado: (2015) -
Role of lncRNA BCYRN1 in trophoblast cell physiology and pathogenesis of preeclampsia
por: Chen, Liping, et al.
Publicado: (2021) -
Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase
por: Gao, Tianxiao, et al.
Publicado: (2023) -
New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma
por: Yi, Wu, et al.
Publicado: (2022) -
CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase
por: Yang, Jing, et al.
Publicado: (2022)